HCW Biologics (HCWB) Operating Margin (2022 - 2025)
Historic Operating Margin for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 21095.26%.
- HCW Biologics' Operating Margin fell 202312000.0% to 21095.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 2817.99%, marking a year-over-year decrease of 17572800.0%. This contributed to the annual value of 1148.5% for FY2024, which is 2435400.0% down from last year.
- According to the latest figures from Q3 2025, HCW Biologics' Operating Margin is 21095.26%, which was down 202312000.0% from 52886.67% recorded in Q2 2025.
- HCW Biologics' Operating Margin's 5-year high stood at 60.33% during Q1 2022, with a 5-year trough of 52886.67% in Q2 2025.
- Moreover, its 4-year median value for Operating Margin was 803.09% (2024), whereas its average is 8932.1%.
- Per our database at Business Quant, HCW Biologics' Operating Margin skyrocketed by 121338200bps in 2024 and then plummeted by -504408600bps in 2025.
- Quarter analysis of 4 years shows HCW Biologics' Operating Margin stood at 422.45% in 2022, then crashed by -93bps to 813.31% in 2023, then rose by 1bps to 803.09% in 2024, then tumbled by -2527bps to 21095.26% in 2025.
- Its Operating Margin was 21095.26% in Q3 2025, compared to 52886.67% in Q2 2025 and 38811.49% in Q1 2025.